Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) [Phase 2]
Phase 2 trial update evaluating safety and efficacy of different oral doses of BAY94-8862 in Japanese subjects with type 2 diabetes and diab…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea [Phase 4]
Phase 4 trial updating the effect of continuous positive airway pressure (CPAP) on albuminuria in patients with diabetic nephropathy and obs…
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) [Phase 4]
Phase 4 clinical trial update on the effect of sarpogrelate in diabetic nephropathy, completed.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Effect of Sulodexide in Overt Diabetic Nephropathy [Phase 4]
Phase 4 trial update for sulodexide in overt diabetic nephropathy; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Possible Role of Roflumilast in Diabetic Nephropathy [Phase 3]
A Phase 3 clinical trial is investigating the possible role of roflumilast in diabetic nephropathy; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes [Phase 4]
Phase 4 trial assessing acute renal oxygenation and autonomic function effects of SGLT2 inhibition in type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Magnesium Supplementation in Diabetic Nephropathy [Phase 2]
Phase 2 clinical trial on magnesium supplementation for diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN) [Phase 3]
A Phase 3 clinical trial assessing metabolic effects of empagliflozin in patients with diabetic nephropathy was terminated.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Effects of Fenofibrate Therapy in Diabetic Nephropathy [Phase 3]
A Phase 3 clinical trial update examining the effects of fenofibrate therapy in diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Bosentan Use in Patients With Diabetic Nephropathy [Phase 3]
A Phase 3 clinical trial investigating bosentan in patients with diabetic nephropathy has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-05-11Clinical Trial Update: Nephropathy In Type 2 Diabetes and Cardio-renal Events [Phase 4]
Phase 4 trial update on nephropathy in type 2 diabetes with cardio-renal events; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients [Phase 4]
Phase 4 trial assessing the effect of an SGLT2 inhibitor on proteinuria in patients with diabetic nephropathies.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy [Phase 4]
Phase 4 trial evaluating exenatide's effect on 24h urinary albumin excretion rate in patients with diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Short Term Effects of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink on Cardiac Relaxation and Urinary Albumin Excretion in a Group of Diabetic Type 2 Subjects [Phase 4]
Phase 4 clinical trial evaluating short-term effects of a Hibiscus sabdariffa and Stevia rebaudiana drink on cardiac relaxation and urinary …
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination [Phase 2]
Phase 2 clinical trial update assessing the efficacy of ACE inhibitors, MRAs, and a combination therapy in diabetic nephropathy with microal…
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy [Phase 3]
Phase 3 trial evaluating the effects of canagliflozin on renal and cardiovascular outcomes in patients with type 2 diabetes and diabetic nep…
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Use of Wharton Jelly in Diabetic Nephropathy [Phase 1, Phase 2]
Clinical trial update for use of Wharton jelly in diabetic nephropathy across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Atrasentan Spermatogenesis and Testicular Function [Phase 2]
Phase 2 trial update on atrasentan focusing on effects on spermatogenesis and testicular function in nephropathy and diabetes patients; resu…
-
CLINICAL_TRIALS trial_result · 2019-04-24Clinical Trial Update: Study Of Diabetic Nephropathy With Atrasentan [Phase 3]
Phase 3 trial of atrasentan for diabetic nephropathy was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy [Phase 2]
A Phase 2, placebo-controlled trial evaluating PF-00489791 in patients with type 2 diabetes and overt nephropathy has been completed with re…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy [Phase 2]
A Phase 2 study of pamrevlumab (FG-3019) in subjects with type 2 diabetes mellitus and diabetic kidney disease on ACE inhibitors or ARBs has…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy [Phase 2]
A Phase 2 clinical trial is evaluating the effect of green tea extract on soluble RAGE in patients with diabetic nephropathy. The current st…
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY) [Phase 4]
Phase 4 trial PENFOSIDINE is evaluating pentoxifylline in patients with diabetic nephropathy and chronic kidney disease stage 3-4; the curre…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria [NA]
Clinical trial update on low-dose colchicine in patients with Type 2 diabetes mellitus and microalbuminuria. The current status of the trial…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria [Phase 2, Phase 3]
Phase 2/3 trial evaluating proteomic prediction and renin-angiotension-aldosterone system inhibition to prevent early diabetic nephropathy i…